 |
|
|
|
Certification
I would like to thank you for all your efforts to choose the correct atomizer for our spray dryer,High speed drying. The surface area of Raw Material liquid increased a lot after atomization through nebulizer, 95%-98% of moisture will be evaporated in high temperature airflow in a flash, only needs seconds time.
 |
—— Fatih BÜYÜKEGEN
I really don't know how to thank you, you are my angel, Thank you very much. Super Fine Pulverizing this one is faster than other same power machine and is easy to operate and repaired.
 |
—— Hamid Doroudian
- I'm Online Chat Now
Company News
 |
Researchers have halted a clinical trial testing sildenafil citrate – the active ingredient in Pfizer’s Viagra – in pregnant women, following reports of baby deaths. A clinical trial in the Netherlands exploring the use of sildenafil in pregnant women, whose babies had severe, early-onset foetal ... Read More
|
 |
Aquestive’s NDA to the US FDA was knocked back over API issues, but the company still expects the product to be available by 2020. The firm’s tadalafil oral film candidate is a generic version of Eli Lilly’s Cialis, a treatment for erectile dysfunction. The New Jersey-headquartered firm is readying ... Read More
|
 |
FDA issues Sunovion a complete response letter in regard to its NDA for its Parkinson’s disease treatment. Sunovion Pharmaceuticals’ new drug application (NDA) for its Parkinson’s disease treatment, apopmorphine sublingual film, designed to treat OFF episodes, was met with a complete response letter ... Read More
|
 |
FDA approves first and only oral film formulation drug for seizures associated with Lennox-Gastaut syndrome. Aquestive Therapeutics’ drug Sympazan (clobazam), an oral film for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older, was ... Read More
|
 |
Lonza and Emerald Health enter an agreement for the large-scale manufacturing of a synthetic derivative of CBD and its oral drug product for the treatment of MS and other CNS diseases. Lonza will be supporting Emerald Health Pharmaceuticals through clinical trials of its synthetic derivative of ... Read More
|
 |
The approval of the farm bill has intensified interest in CBD but Nexien BioPharma CEO warns pharma-grade products are needed for patients with serious conditions. Last year, two major pieces of news broke that generated a huge amount of interest in using cannabinoid (CBD) therapeutically: the first ... Read More
|
 |
Noramco partners with Nemus to produce an analogue of cannabidiol that possesses greater bioavailability, that could be used to treat diseases of the retina. Nemus Bioscience secured the services of Noramco to manufacture and assist in the scale up process of its cannabidiol (CBD) analogue, ... Read More
|
 |
The newly approved generic version of valsartan will be produced by Alkem Laboratories, an Indian company headquartered in Mumbai. The US Food and Drug Administration (FDA) stated that it had prioritised the review of Alkem’s drug application to provide an additional supply of valsartan medication, ... Read More
|
 |
Alberto Vacchi, Chairman of IMA, received the honour of Cavaliere del Lavoro (Order of Merit for Labour) from the President of the Italian Republic, Sergio Mattarella, during a ceremony held on 8 November 2018 in the splendid setting of the Palazzo del Quirinale. A law graduate and industrialist, ... Read More
|
 |
With the advancement of the pharmaceutical drugs, along with the regulatory standards associated with their commercialization, manufacturers must come up with a framework to include new pharma equipment for drug research and discovery (R&D). As a result, all the equipment employed across the pharma ... Read More
|
Page 1 of 1